{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:10:32Z","timestamp":1784214632717,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mce.2021.111484","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T17:24:30Z","timestamp":1633973070000},"page":"111484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Antiproliferative effects of metformin in cellular models of pheochromocytoma"],"prefix":"10.1016","volume":"539","author":[{"given":"Cinthia Gabriel","family":"Meireles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Louren\u00e7o de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Martins de Paula Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-0027","authenticated-orcid":false,"given":"Rafael","family":"Abe da Rocha Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teisha","family":"Yo-Stella Brashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7622-1550","authenticated-orcid":false,"given":"Eliete","family":"Neves da Silva Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"de Assis Rocha Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-290X","authenticated-orcid":false,"given":"Luiz Alberto","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9590-1631","authenticated-orcid":false,"given":"Adriana","family":"Lofrano-Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2021.111484_bib1","first-page":"1","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"28","author":"Andrzejewski","year":"2014","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.mce.2021.111484_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2021.111484_bib3","doi-asserted-by":"crossref","first-page":"E2000","DOI":"10.3390\/ijms17122000","article-title":"Metformin inhibits TGF-\u03b21-induced epithelial-to-mesenchymal transition via PKM2 relative-mTOR\/p70s6k signaling pathway in cervical carcinoma cells","volume":"17","author":"Cheng","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2021.111484_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0046-8177(98)90070-3","article-title":"Prognostic markersin pheochromocytoma","volume":"29","author":"Clarke","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mce.2021.111484_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-14-59","article-title":"Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA","volume":"14","author":"Costa","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.mce.2021.111484_bib6","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/annonc\/mdw410","article-title":"Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis","volume":"27","author":"Coyle","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mce.2021.111484_bib7","first-page":"108","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat. Ver. Cancer."},{"key":"10.1016\/j.mce.2021.111484_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1530\/ERC-16-0329","article-title":"mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors","volume":"23","author":"Falletta","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2021.111484_bib10","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/en.2019-00410","article-title":"Synergistic highly potent targeted drug combinations in different pheochromocytoma models including human tumor cultures","volume":"160","author":"Fankhauser","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2021.111484_bib11","doi-asserted-by":"crossref","first-page":"a001057","DOI":"10.1101\/cshperspect.a001057","article-title":"p53 regulation of the IGF-1\/AKT\/mTOR pathways and the endosomal compartment","volume":"2","author":"Feng","year":"2010","journal-title":"Cold. Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.mce.2021.111484_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMcibr1409796","article-title":"The target of metformin in type 2 diabetes","volume":"371","author":"Ferrannini","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2021.111484_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.hoc.2015.09.006","article-title":"Pheochromocytoma and paraganglioma: genetics, diagnosis, and treatment","volume":"30","author":"Fishbein","year":"2016","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.mce.2021.111484_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"13","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2021.111484_bib15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2021.111484_bib16","article-title":"Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: a meta-analysis","volume":"95","author":"He","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.mce.2021.111484_bib17","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/cncr.23812","article-title":"Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients","volume":"113","author":"Huang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2021.111484_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12672-015-0231-4","article-title":"Pheochromocytoma: gasping for air","volume":"6","author":"Jochmanov\u00e1","year":"2015","journal-title":"Horm. Cancer."},{"key":"10.1016\/j.mce.2021.111484_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2021.111484_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2021.111484_bib21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jcb.23000","article-title":"Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells","volume":"112","author":"Lee","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2021.111484_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-16-0324","article-title":"Targeting PI3K\/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo","volume":"24","author":"Lee","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2021.111484_bib23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111484_bib24","first-page":"3253","article-title":"Metformin suppresses proliferation and viability of rat pheochromocytoma cells","volume":"23","author":"Li","year":"2017","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.mce.2021.111484_bib25","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.mce.2021.111484_bib26","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","article-title":"Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes","volume":"25","author":"Margel","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2021.111484_bib27","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1021\/bi501473h","article-title":"Selective inhibition of deactivated mitochondrial complex I by biguanides","volume":"54","author":"Matsuzaki","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111484_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2017.07.120","article-title":"Effects of metformin on endometrial cancer: systematic review and meta-analysis","volume":"147","author":"Meireles","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mce.2021.111484_bib29","first-page":"545","article-title":"Williams textbook of Endocrinology","volume":"16","author":"Melmed","year":"2011","journal-title":"Endocrine Hypertension Chapter"},{"key":"10.1016\/j.mce.2021.111484_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin: mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2021.111484_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/onc.2012.181","article-title":"Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects","volume":"32","author":"Pierotti","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2021.111484_bib32","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2850","article-title":"Measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in culture cells for assessment of the energy metabolism","volume":"8","author":"Plitzko","year":"2018","journal-title":"Bio-protocol"},{"key":"10.1016\/j.mce.2021.111484_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.31768\/2312-8852.2017.39(4):264-268","article-title":"Cytotoxic activity of metformin in vitro does not correlate with its antitumor action in vivo","volume":"39","author":"Pyaskovskaya","year":"2017","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.mce.2021.111484_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.oraloncology.2015.01.007","article-title":"Effects of metformin on head and neck cancer: a systematic review","volume":"51","author":"R\u00eago","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.mce.2021.111484_bib35","doi-asserted-by":"crossref","first-page":"E615","DOI":"10.1152\/ajpendo.00035.2011","article-title":"Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2\/Akt\/mTOR\/S6K1 pathways through modulation of Bcl-2 and BAD","volume":"302","author":"Saito","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111484_bib36","first-page":"119","article-title":"Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"San-Millan","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2021.111484_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5966\/sctm.2012-0058","article-title":"Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK","volume":"1","author":"Sato","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.mce.2021.111484_bib38","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/15384101.2016.1186316","article-title":"Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-beta2","volume":"15","author":"Seliger","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mce.2021.111484_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0123721","article-title":"Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response","volume":"10","author":"Sesen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2021.111484_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2014.08.012","article-title":"The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1\/hypoxia-inducible factor-1alpha signaling pathway in ELT-3 cells","volume":"399","author":"Tadakawa","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2021.111484_bib41","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1158\/1078-0432.CCR-17-3167","article-title":"Metformin targets mitochondrial glycerophosphate dehydrogenase to control rate of oxidative phosphorylation and growth of thyroid cancer in vitro and in vivo","volume":"16","author":"Thakur","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2021.111484_bib42","first-page":"34495","article-title":"Differential dependence of hypoxia inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2","volume":"12","author":"Toschi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111484_bib43","doi-asserted-by":"crossref","first-page":"110803","DOI":"10.1016\/j.mce.2020.110803","article-title":"A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells","volume":"509","author":"Vitali","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2021.111484_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04.009","article-title":"Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer","volume":"164","author":"Wigerup","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mce.2021.111484_bib45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1634\/theoncologist.2015-0096","article-title":"Metformin use is associated with better survival of breast cancer patients with diabetes: a meta-analysis","volume":"20","author":"Xu","year":"2015","journal-title":"Oncol."},{"key":"10.1016\/j.mce.2021.111484_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.18632\/oncotarget.6418","article-title":"Metformin suppresses hypoxia-induced stabilization of HIF-1' through reprogramming of oxygen metabolism in hepatocellular carcinoma","volume":"7","author":"Zhou","year":"2015","journal-title":"Oncotarget"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:20:36Z","timestamp":1759587636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720721003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"alternative-id":["S0303720721003282"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111484","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiproliferative effects of metformin in cellular models of pheochromocytoma","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111484"}}